NextFin news, On Thursday, September 18, 2025, the US Embassy in New Delhi announced it has revoked and denied visas of several Indian business executives and corporate leaders, along with their close family members, for their alleged involvement in trafficking fentanyl precursors to the United States.
The visa actions were taken under sections 221(i), 212(a)(2)(C), and 214(b) of the US Immigration and Nationality Act, which may render the affected individuals and their families ineligible to travel to the US. The embassy also stated it will subject executives linked to companies known for trafficking fentanyl precursors to heightened scrutiny in future visa applications.
Charge d’affaires Jorgan Andrews of the US Embassy emphasized the mission's commitment to combating illicit drug trafficking, stating, "Individuals and organisations involved in the illegal production and trafficking of drugs to the United States, along with their families, will face consequences that may include being denied access to the United States."
Fentanyl is a potent synthetic opioid, up to 100 times stronger than morphine, responsible for a significant number of overdose deaths in the US. The US has reported over 70,000 overdose deaths linked to synthetic opioids like fentanyl in 2024 alone, according to preliminary data from the Centers for Disease Control and Prevention.
The US Drug Enforcement Administration (DEA) notes that while finished fentanyl largely originates from Mexican cartels, the chemical precursors primarily flow from Asia. Historically, China was the main source, but following its crackdown on fentanyl exports in 2019, traffickers have increasingly rerouted operations through India, where some chemical manufacturers have been implicated in precursor exports to criminal organizations.
The US Embassy expressed appreciation for India's cooperation in addressing this transnational threat, highlighting the importance of joint efforts to keep citizens safe from illicit drugs. The embassy also referenced the Trump administration's prior executive orders aimed at securing borders, combating drug trafficking organizations, and demanding reforms from source countries.
The embassy declined to disclose the names of the individuals or companies involved, citing ongoing investigations. There was no immediate comment from the Indian government on the visa revocations.
This move represents a significant escalation in US efforts to stem the flow of synthetic opioids into the country and signals continued close cooperation between the US and India on combating drug trafficking.
Explore more exclusive insights at nextfin.ai.
